Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 10 AND SODIUM CHLORIDE 0 45 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 10 AND SODIUM CHLORIDE 0 45 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER.
DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides a source of carbohydrates to increase blood glucose concentrations, while sodium chloride acts as a source of electrolytes to maintain osmotic pressure and fluid balance.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Intravenous infusion. Dose is individualized based on fluid, electrolyte, and caloric needs. Typical adult maintenance: 100-200 mL/hour of D10 0.45% NaCl, providing 10-20 g/hour dextrose and 77-154 mEq/L sodium. Maximum infusion rate: 0.5-0.8 g/kg/hour dextrose.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
None Documented
None Documented
For exogenous glucose, the terminal elimination half-life is approximately 2-4 hours in healthy individuals, but may be prolonged in renal impairment or diabetes due to altered insulin dynamics. Sodium and chloride have no defined half-life as electrolytes; their renal clearance maintains homeostasis.
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Dextrose is metabolized to carbon dioxide and water; excretion of unchanged glucose in urine is minimal (<0.5%) in euglycemic patients. Sodium and chloride are primarily excreted renally (90-95%) with minor fecal loss (<5%).
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Category A/B
Category C
Electrolyte
Electrolyte